Litcius/Paper detail

Strategies for the Management of Spike Protein-Related Pathology

Matthew Halma, Christof Plothe, Paul E. Marik, Theresa A Lawrie

2023Microorganisms18 citationsDOIOpen Access PDF

Abstract

In the wake of the COVID-19 crisis, a need has arisen to prevent and treat two related conditions, COVID-19 vaccine injury and long COVID-19, both of which can trace at least part of their aetiology to the spike protein, which can cause harm through several mechanisms. One significant mechanism of harm is vascular, and it is mediated by the spike protein, a common element of the COVID-19 illness, and it is related to receiving a COVID-19 vaccine. Given the significant number of people experiencing these two related conditions, it is imperative to develop treatment protocols, as well as to consider the diversity of people experiencing long COVID-19 and vaccine injury. This review summarizes the known treatment options for long COVID-19 and vaccine injury, their mechanisms, and their evidentiary basis.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)HarmSpike (software development)Spike ProteinEtiologyMedicine2019-20 coronavirus outbreakIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PsychologyPathologyOutbreakDiseaseComputer scienceSocial psychologySoftware engineeringInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19Peripheral Neuropathies and Disorders
Strategies for the Management of Spike Protein-Related Pathology | Litcius